Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The 2.4mg dose of semaglutide represents the highest standard dose used in clinical weight loss programs, but reaching this level doesn't automatically mean your weight loss journey ends. Real-world data shows that patients continue losing weight at this dose for many months, though the rate of loss may slow compared to earlier dose escalations. PlexusDx helps you understand whether your individual genetics support continued response to semaglutide at any dose level.
Does Weight Loss Continue at the 2.4mg Semaglutide Dose?
Clinical trials demonstrate that semaglutide produces sustained weight loss even after patients reach the 2.4mg maintenance phase. Participants in the STEP trials who stayed on 2.4mg for the full treatment period continued to lose weight throughout the study, though the rate typically slowed after the first 16 weeks of therapy. This pattern reflects how GLP-1 receptors work: they suppress appetite and slow gastric emptying continuously, not just during the dose-escalation phase.
Most patients lose 15 to 22 percent of their body weight by week 68 of treatment on 2.4mg semaglutide. Individual results vary significantly based on diet, exercise, metabolism, and genetic responsiveness to GLP-1 signaling. Some people experience steady month-to-month losses, while others see plateaus lasting 4 to 8 weeks before the scale shifts again. These variations are completely normal and do not indicate treatment failure.
Why Weight Loss Slows Down at Higher Doses
As your body adjusts to semaglutide, a phenomenon called tachyphylaxis can occur, meaning your cells become less sensitive to the medication over time. This doesn't mean the drug stops working—it means your weight loss rate may decrease from 1–2 pounds per week during early treatment to 0.5–1 pound per week at maintenance. This slowdown is expected and represents your body reaching a new equilibrium rather than the medication failing.
Calorie intake and activity patterns also influence how much weight you continue to lose at 2.4mg. Semaglutide reduces hunger and food cravings, but it doesn't create an unlimited calorie deficit on its own. If you return to pre-treatment eating patterns or reduce physical activity, weight loss naturally plateaus or reverses, even on the highest dose. PlexusDx treatment plans include dietary and lifestyle counseling to maintain momentum.
Genetic Factors That Affect Your Response to 2.4mg Semaglutide
Your DNA influences how efficiently your GLP-1 receptors respond to semaglutide and how your body regulates appetite and metabolism. Key genetic variants such as GLP1R rs6923761, MC4R rs17782313, and FTO rs9939609 affect the strength of your natural GLP-1 signaling and your baseline metabolic rate. People with specific variants in these genes may lose weight faster or slower on semaglutide, regardless of the dose they're taking.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 peptide-related pathways and 150+ genetic insights to reveal how your unique biology interacts with semaglutide. This test identifies whether your genetics support strong sustained response to GLP-1 therapy at the 2.4mg dose or whether adding a second medication like tirzepatide (which targets GLP-1 and GIP receptors) might unlock better results. Understanding your peptide pathway genetics helps PlexusDx clinicians personalize your treatment plan for maximum long-term success.
Maximizing Weight Loss Results Beyond 2.4mg Semaglutide
If your weight loss plateaus at 2.4mg semaglutide despite consistent adherence and lifestyle effort, PlexusDx offers alternative compounded formulations to reignite progress. Oral semaglutide delivers the same active ingredient in tablet form, which some patients tolerate better and experience renewed weight loss. Compounded tirzepatide (a dual GLP-1/GIP receptor agonist) activates two appetite-suppressing pathways simultaneously, offering a different mechanism that may overcome plateaus when semaglutide alone reaches its limits.
GLP-Squared, PlexusDx's dual-compound injection combining semaglutide and tirzepatide, provides synergistic activation of both GLP-1 and GIP signaling in a single weekly injection. This approach reflects cutting-edge weight loss science and allows patients to benefit from complementary mechanisms without requiring two separate medications. PlexusDx compounding pharmacies prepare all these formulations under strict 503A standards, ensuring pharmaceutical quality and consistency at prices that start at $149/mo for semaglutide injection—your dose may need to go up, your price won't.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it normal to stop losing weight on 2.4mg semaglutide after a few months?
Yes, weight loss naturally slows after the initial rapid phase, but this is not the same as stopping completely. Most patients on 2.4mg semaglutide continue to lose weight throughout treatment, often 0.5–1 pound per week. If you notice no scale movement for 8+ weeks, PlexusDx clinicians can evaluate your dosing schedule, dietary adherence, and genetic factors to determine whether a medication adjustment is needed.
Do people regain weight once they stop semaglutide?
Weight regain after stopping semaglutide is common because the medication's appetite-suppressing effects wear off. Studies show that many people regain 50% of lost weight within one year of stopping, which is why PlexusDx emphasizes long-term treatment continuity. Maintaining lifestyle changes (diet and exercise) during and after treatment is critical for preventing rebound weight gain.
How much does semaglutide injections cost per month with PlexusDx?
PlexusDx compounded semaglutide injections start at $149/mo, with no flat per-compound pricing increases as your treatment evolves. The price remains flat across three commitment tiers, and HSA/FSA accounts are accepted. No insurance, membership fee, or subscription lock-in is required to access PlexusDx medications in all 50 states.
Is compounded semaglutide as safe as the brand-name Wegovy?
PlexusDx compounded semaglutide is prepared by licensed 503A compounding pharmacies under strict quality and sterility standards. While compounded medications are not FDA-approved as finished products, they contain the same active pharmaceutical ingredient as Wegovy. Your PlexusDx provider monitors your response and side effects just as closely as any traditional weight loss clinic.
Can genetic testing help me know if I'll lose weight well on 2.4mg semaglutide?
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes genetic variants in GLP1R, MC4R, FTO, and 11 other peptide pathways to predict your natural responsiveness to GLP-1 therapy. This test helps your PlexusDx clinician determine whether 2.4mg semaglutide alone is likely to deliver optimal results, or whether dual-pathway therapy with tirzepatide would be more effective for your specific genetics.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can Wegovy Cause Constipation? What You Need to Know About This Common Side Effect
What is Better: Ozempic or Mounjaro for Weight Loss?